Tenon Medical Inc TNON.OQ TNON.O is expected to show a rise in quarterly revenue when it reports results on November 13 for the period ending September 30 2024
The Los Gatos California-based company is expected to report a 26.1% increase in revenue to $1.19 million from $944 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Tenon Medical Inc is for a loss of $4.23 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Tenon Medical Inc is 22.00, above its last closing price of $3.46.
This summary was machine generated November 12 at 03:52 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments